Old Antabuse Drug Turns Breast Cancer Resistance Against Itself
Chemotherapy has long been a workhorse against metastatic breast cancer, yet for most patients with estrogen receptor-positive (ER+) disease, the cancer eventually wins the evolutionary arms race. Cells that survive treatment pass on their resistance, and once a resistant population takes hold, the tumor becomes progre
